Edgewise Therapeutics Free Cash Flow to Equity (Quarterly) Analysis

Edgewise Therapeutics Inc (EWTX)

29.62 -0.36 (-1.20%) USD | NASDAQ | Dec 24, 16:00

Free Cash Flow to Equity (Quarterly) Chart

View Free Cash Flow to Equity (Quarterly) for EWTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Free Cash Flow to Equity (Quarterly) Chart

Start Trial

Historical Data

View Historical Data

Start Trial

Free Cash Flow to Equity Definition

View Free Cash Flow to Equity Definition

Start Trial

Free cash flow to equity measures the total free cash flow divided by shareholder's equity. This metric can be used as a gauge for cash flow available for shareholders.

Read full definition.

Free Cash Flow to Equity (Quarterly) Range, Past 5 Years

View Free Cash Flow to Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Free Cash Flow to Equity (Quarterly) Benchmarks

View Free Cash Flow to Equity (Quarterly) Benchmarks

Start Trial

Vertex Pharmaceuticals Inc	Upgrade
Catalyst Pharmaceuticals Inc	Upgrade
Sarepta Therapeutics Inc	Upgrade
Regenxbio Inc	Upgrade
Entrada Therapeutics Inc	Upgrade

Free Cash Flow to Equity (Quarterly) Related Metrics

Cash from Operations (Quarterly)	Upgrade
Cash from Investing (Quarterly)	Upgrade
Cash from Financing (Quarterly)	Upgrade
Free Cash Flow	Upgrade
Free Cash Flow Per Share (Quarterly)	Upgrade
Free Cash Flow Yield	Upgrade